PCV44 Economic Evaluation of a Single-Pill Triple Combination With Valsartan, Amlodipine and Hydrochlorothiazide Against Its Dual Components in Greece. The Generic Substitution Case
Abstract
Authors
P. Stafylas G. Kourlaba D. Georgiopoulos M. Hatzikou N. Maniadakis